Several studies have shown that the activation of the kynurenine (KYN) pathway in patients with depression is secondary to increased levels of the inflammatory cytokines interleukin (IL)-6, interferon (IFN)-α and tumor necrosis factor (TNF)-α [[6], [7], [8]]. Here, IL6 is linked to depressive symptom measurement.